EP3677266
EXON 18 AND/OR EXON 21 MUTANT EGFR SELECTIVE INHIBITOR
:
EP einkaleyfi: Þýðing ekki lögð inn:
31.8.2018:
17.1.2024:
18851555.5
:
30.8.2038
:
EXON 18 AND/OR EXON 21 MUTANT EGFR SELECTIVE INHIBITOR
31.8.2018
17.1.2024
:
Taiho Pharmaceutical Co., Ltd.:
1-27, Kandanishiki-cho, Chiyoda-ku, Tokyo 101-8444, JP
:
ABE, Naomi:
Tsukuba-shi Ibaraki 300-2611, JP
:
HASAKO, Shinichi:
Tsukuba-shi Ibaraki 300-2611, JP
:
2017168606:
1.9.2017:
JP
:
JP2018032314:
31.8.2018
:
A61K 31/519, A61P 35/00, C12N 9/99